News
Joint preventive action of GHC Genetics with the OZP insurance company
03. 12. 2024
GHC Genetics, in partnership with the Health insurance company for bank, insurance company and civil engineering employees (OZP), is offering a limited-time discounted promotion for its insureds. From 1 December 2024 to 1 January 2025, they can take advantage of a Christmas 50% discount and pay only CZK 1,200 for a TromboGen Plus examination . The test can detect early a genetic predisposition to increased blood clotting, which is associated with an increased risk of thrombosis and subsequent potentially very serious complications. Deep vein thrombosis, pulmonary embolism, heart attack or stroke are serious diseases that affect even people who live a healthy lifestyle, exercise, are of normal weight and have normal blood sugar and cholesterol levels.
Updated indication criteria for genetic testing of hereditary cancer syndromes
19. 11. 2024
On 9 October 2024, the Committee of the Society of Medical Genetics and Genomics of the Czech Medical Society J.E.Purkyně approved the updated extended indication criteria for germline genetic testing for the most common adult cancers. The list of criteria can be found in the download section of our website and in the appendix of this report.
More infoWe offer a new examination "Pharmacogenetics of statins"
13. 11. 2024
Statins inhibit the internal production of cholesterol in the liver, leading to a reduction in total and LDL-cholesterol levels in the blood. However, in a proportion of the population, they cause muscular side effects, particularly myopathy, which can lead to the development of rhabdomyolysis. The more common manifestation of myopathy in the form of muscle pain, weakness or fatigue is a common reason why patients stop taking the medication.
More infoDownloads
Magazine
Gallery
GHC Genetics Laboratory
Helping to plant trees
Video Gallery
